UPCOMING SESSIONS in ET
Wed, May 6, 2026
10:00 – 11:00 PM UTC
Webinar: Emerging Roles of TTR in ATTR-CM and Your Overall Health Sarah C Paciulli Click To Register
UPCOMING SESSIONS in ET
Wed, May 6, 2026 · 10:00 – 11:00 PM UTC
Webinar: Emerging Roles of TTR in ATTR-CM and Your Overall Health
Sarah C Paciulli
Click To Register
View all sessions

Light chain (AL) Amyloidosis/Primary

U.S. Department of Veterans Affairs: AL Amyloidosis and Agent Orange
AL Amyloidosis and Agent Orange Veterans who develop AL amyloidosis and were exposed to Agent Orange or other herbicides during military service do not have to…
Read more
Dysphagia Unveiling Systemic Immunoglobulin Light-Chain Amyloidosis With Multiple Myeloma
Dysphagia is an uncommon presentation of systemic immunoglobulin light-chain (AL) amyloidosis with multiple myeloma (MM). Gastrointestinal (GI) involvement usually…
Read more
AL Amyloidosis Presenting With Limb Girdle Myopathy
An elderly Caucasian man presented with a 10-month history of proximal myopathy and dysphagia. His serum creatine kinase (CK) was elevated at 877 U/L (normal 40-320…
Read more
Management of Systemic AL Amyloidosis: Recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group
Systemic AL amyloidosis is a plasma cell dyscrasia with a characteristic clinical phenotype caused by multi-organ deposition of an amyloidogenic monoclonal protein…
Read more
Subscribe to